Graziella Privitera
Overview
Explore the profile of Graziella Privitera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Candido S, Lumera G, Barcellona G, Vetri D, Tumino E, Platania I, et al.
Exp Ther Med
. 2020 Nov;
20(6):237.
PMID: 33193842
Multiple factors play a pathophysiologic role for the venous thromboembolism (VTE) as a multi-factorial disease. Inflammation might play a peculiar role in shifting towards a pro-thrombotic state. Anticoagulant drugs are...
2.
Di Mauro S, Scamporrino A, Petta S, Urbano F, Filippello A, Ragusa M, et al.
Liver Int
. 2019 Jun;
39(9):1742-1754.
PMID: 31169972
Background & Aims: In patients with non-alcoholic fatty liver disease (NAFLD), liver biopsy is the gold standard to detect non-alcoholic steatohepatitis (NASH) and stage liver fibrosis. We aimed to identify...
3.
Privitera G, Figorilli F, Jalan R, Mehta G
Gastroenterology
. 2018 Aug;
155(5):1649-1650.
PMID: 30118744
No abstract available.
4.
Privitera G, Spadaro L, Marchisello S, Fede G, Purrello F
Dig Dis Sci
. 2017 Nov;
63(1):16-26.
PMID: 29177578
Progressive lipoprotein impairment occurs in liver cirrhosis and is associated with increased morbidity and mortality. The present review aims to summarize the current evidence regarding the prognostic value of lipoprotein...
5.
Costantino G, Podda G, Falsetti L, Iannone P, Lages A, Marra A, et al.
Intern Emerg Med
. 2016 Dec;
12(5):693-703.
PMID: 27905006
Several guidelines often exist on the same topic, sometimes offering divergent recommendations. For the clinician, it can be difficult to understand the reasons for this divergence and how to select...
6.
Privitera G, Meli G
Gastroenterol Hepatol Bed Bench
. 2016 Nov;
9(4):335-339.
PMID: 27895861
Chronic anemia is common in liver cirrhosis. In this setting, the pathogenesis of anemia is complex and multifactorial. Spur cell anemia is a serious disorder in cirrhotic patients and is...
7.
Bertino G, Privitera G, Purrello F, Demma S, Crisafulli E, Spadaro L, et al.
Intern Emerg Med
. 2016 Jun;
11(7):905-16.
PMID: 27273018
Liver cirrhosis is a major cause of morbidity and mortality worldwide, mainly due to complications of portal hypertension. In this article, we review the current understanding on the pathophysiology, the...
8.
Privitera G, Spadaro L, Alagona C, Calanna S, Piro S, Rabuazzo A, et al.
Acta Diabetol
. 2015 Oct;
53(3):449-59.
PMID: 26496770
Aims: Fat accumulation in the liver and in the muscle results in hepatic and muscle insulin resistance and has been associated with increased cardiovascular risk. It is unclear whether the...
9.
Fede G, Spadaro L, Privitera G, Tomaselli T, Bouloux P, Purrello F, et al.
Dig Liver Dis
. 2015 Sep;
47(12):1047-51.
PMID: 26364559
Background: Adrenal insufficiency is often present in cirrhosis. We hypothesize that a prolonged adrenocorticotropic hormone (ACTH) stimulus can restore cellular capacity of adrenal glands to secrete cortisol. Aim of our...
10.
Spadaro L, Privitera G, Fede G, Magliocco O, Russello M, Piro S, et al.
Intern Emerg Med
. 2015 Apr;
10(6):703-9.
PMID: 25863499
Renal failure is a common complication of cirrhosis and is associated with poor prognosis. Several reports have demonstrated the clinical utility of renal resistive indices in the assessment of renal...